Shunsuke Kondo

Professor

Tokyo Women's Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Shunsuke Kondo is a Professor at Tokyo Women's Medical University in Japan. His research primarily focuses on oncology, specifically in the areas of advanced solid tumors, hemostasis techniques in gastrointestinal cancers, and pharmacological therapies for hepatocellular carcinoma. He has contributed to several studies including the efficacy of novel inhibitors and the genetic profiling of cancer in Asian patients.

Articles (10)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (5)

Taroh Satoh

Osaka University Hospital

JAPAN

View details

Masashi Enomoto

Chugai Pharmaceutical

UNITED STATES

View details

Masatoshi Kudo

Professor and Chairman

Kindai University Faculty of Medicine

JAPAN

View details

Yuan Gu

Stanford University

UNITED STATES

View details

Yoshito Komatsu

Hokkaido University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shunsuke Kondo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Final Results from a First-in-Human Phase 1 Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations

Phase II trial of niraparib for BRCA -mutated biliary tract, pancreatic and other gastrointestinal cancers: NIR-B

Phase I Study of Simlukafusp Alfa (FAP-IL2v) with or without Atezolizumab in Japanese Patients with Advanced Solid Tumors

Efficacy of hemostasis by gastroduodenal covered metal stent placement for hemorrhagic duodenal stenosis due to pancreatobiliary cancer invasion: a retrospective study

PD‐1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study

Safety, tolerability, pharmacokinetics, and antitumor activity of adavosertib in Japanese patients with advanced solid tumors: A phase I, open-label study

Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study

Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian Patients

Recent updates in the use of pharmacological therapies for downstaging in patients with hepatocellular carcinoma

Diagnostic Ability of Endoscopic Ultrasound-Guided Tissue Acquisition Using 19-Gauge Fine-Needle Biopsy Needle for Abdominal Lesions

Collaborators (5)

Taroh Satoh

Masashi Enomoto

Masatoshi Kudo

Yuan Gu

Yoshito Komatsu

Make your next move.